IGMS Share Price Performance
US$1.27
-9.18 (-87.85%)
Price US$1.27
Share PriceUS$1.27
IGMS Community Narratives
There are no narratives available yet.
Recent IGMS News & Updates
IGM Biosciences, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.89
- Gross Margin
- -3.79%
- Net Profit Margin
- -36.80%
- Debt/Equity Ratio
- 0%
IGM Biosciences, Inc. Competitors
Snowflake Analysis
About IGMS
- Founded
- 1993
- Employees
- 16
- CEO
- WebsiteView website
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Market Insight
Market sentiment on BTC treasury companies is moving, and with volatility rising, disagreements over their future prospects are as heated as ever.
Continue reading
U.S. Market Performance
- 7 Days: 0.5%
- 3 Months: 11.7%
- 1 Year: 15.7%
- Year to Date: 10.1%
The market has been flat over the last week. More promisingly, the market is up 16% over the past year. Earnings are forecast to grow by 15% annually. Market details ›